A phage display-based approach to investigate abnormal neovessels of the retina

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4371-4379

  Staniszewska, Magdalena ^a   Gu, Xiaolin ^b   Romano, Carmelo ^b   Kazlauskas, Andrius ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA SEQUENCE; NEWBORN; NONHUMAN; OXYGEN INDUCED RETINOPATHY; PEPTIDE LIBRARY; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PIGMENT EPITHELIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RETINA NEOVASCULARIZATION; RETINOPATHY; SCANNING ELECTRON MICROSCOPY; STAINING;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; OXYGEN; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 84863753800     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9690     Document Type: Article

References (24)

1. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438:960-966.
2. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248:915-930.
3. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136:122-135.
4. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
5. Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34:576-585.
6. Stahl A, Connor KM, Sapieha P, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51: 2813-2826.
7. Barnett JM, Yanni SE, Penn JS. The development of the rat model of retinopathy of prematurity. Doc Ophthalmol. 2010; 120:3-12.
8. Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci. 1995;36: 2063-2070.
9. Pasqualini R, Koivunen E, Ruoslahti E. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol. 1995;130:1189-1196.
10. Romeo G, Frangioni JV, Kazlauskas A. Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction. FASEB J. 2004;18:725-727.
11. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ Res. 2007;101:357-367.
12. Lei H, Venkatakrishnan A, Yu S, Kazlauskas A. Protein kinase Adependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J Biol Chem. 2007;282:9364-9371.
13. Pasqualini R, Koivunen E, Kain R, et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 2000;60:722-727.
14. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 1996;380:364-366.
15. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest. 1998;102: 430-437.
16. Rajotte D, Ruoslahti E. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J Biol Chem. 1999;274:11593-11598.
17. Kelly KA, Waterman P, Weissleder R. In vivo imaging of molecularly targeted phage. Neoplasia. 2006;8:1011-1018.
18. Kelly KA, Setlur SR, Ross R, et al. Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res. 2008;68:2286-2291.
19. Kelly KA, Nahrendorf M, Yu AM, Reynolds F, Weissleder R. In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol. 2006;8:201-207.
20. Oku N, Asai T, Watanabe K, et al. Anti-neovascular therapy using novel peptides homing to angiogenic vessels. Oncogene. 2002;21:2662-2669.
21. Barbas CF, Burton DR, Scott J, Silverman GJ. Phage Display: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001.
22. Cairns JE. Normal development of the hyaloid and retinal vessels in the rat. Br J Ophthalmol. 1959;43:385-393.
23. Takeda A, Baffi JZ, Kleinman ME, et al. CCR3 is a target for agerelated macular degeneration diagnosis and therapy. Nature. 2009;460:225-230.
24. Zhang C, Shen JK, Lam TT, et al. Activation of microglia and chemokines in light-induced retinal degeneration. Mol Vis. 2005;11:887-895.